1 active not recruiting, 1 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Replens: new trials by email Literature Review of Replens trials Research Report on Replens
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors Vaginal Dehydroepiandrosterone, Vaginal Polycarbophil Moisturizer - Vaginal Atrophy, Postmenopausal Symptoms | Phase 2 | Terminated | University of Arkansas | 8 | 2021-06-07 | 2024-11-27 |
| Randomized Trial of Maternal Progesterone Therapy Progesterone, Vaginal lubricant - Congenital Heart Disease, Periventricular Leucomalacia | Phase 2 | Completed | Children's Hospital of Philadelphia | 102 | 2014-07-01 | 2023-08-09 |
| REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy ESTRING, Replens, Vagifem - Estrogen Receptor Positive Breast Cancer, Breast Cancer | Phase 2 | Active not recruiting | Polly A. Niravath, MD | 33 | 2013-09-01 | 2026-01-28 |
Breast Neoplasms (1) · Heart Defects, Congenital (1) · Leukomalacia, Periventricular (1)
Children's Hospital of Philadelphia (1) · Polly A. Niravath, MD (1) · University of Arkansas (1)
United States (3)
Gloria Richard-Davis, MD (1) · J. William Gaynor, MD (1) · Polly Niravath, MD (1)